PRAC Recommendation Regarding Injectable Methylprednisolone Products Containing Lactose


Viewing 0 reply threads
  • Author
    • #49277


      I would like to to share with you the European Medicines Agency (EMA) Pharmacovigilance Risk Assessment Committee (PRAC) recommendation regarding the use of Injectable Methylprednisolone in patients who are allergic to cow’s milk protein. In addition, patients being treated for an allergic reaction with methylprednisolone should have their treatment stopped if their symptoms worsen or they develop new symptoms.

      Solu-Medrol (Methylprednisolone) 40 mg Vials contain Lactose as an inactive ingredient. Lactose can potentially contain traces of cow’s milk proteins. Therefore it must not be used in patients with a known or suspected allergy to the proteins in cow’s milk.

      The other strengths of Solu-Medrol 125 mg, 250 mg, 500 mg and 1000 mg vials do not contain Lactose, so they can be used safely in this patient’s population.

Viewing 0 reply threads

You must be logged in to reply to this topic.

This website uses cookies to improve your experience. By using this website you agree to our Cookie Policy.
Read more